Suppr超能文献

将镰状细胞病新生儿筛查纳入刚果民主共和国布卡武初级卫生保健的试点研究。

Integration of newborn screening for sickle cell disease into primary health care in Bukavu, Democratic Republic of the Congo: a pilot study.

作者信息

Nangunia Nash Mwanza, Mukuku Olivier, Feza Viviane Bianga, Kyembwa Yves Mulindilwa, Kabesha Théophile Barhwamire, Tsongo Zacharie Kibendelwa, Mutombo André Kabamba, Wembonyama Stanislas Okitotsho

机构信息

Faculty of Medicine, Official University of Bukavu, Bukavu, Democratic Republic of the Congo.

Institut Supérieur des Techniques Médicales de Lubumbashi, Lubumbashi, Democratic Republic of the Congo.

出版信息

BMC Prim Care. 2025 Aug 30;26(1):275. doi: 10.1186/s12875-025-02976-x.

Abstract

INTRODUCTION

Sickle cell disease (SCD) is an inherited genetic disorder that represents a major public health challenge in sub-Saharan Africa, particularly in the Democratic Republic of the Congo (DRC). This disease, characterized by an amino acid substitution in the beta-globin chain, requires early management to reduce serious complications and improve patients' quality of life. This study aimed to test the feasibility of integrating newborn screening for SCD into primary health care in Bukavu, in the DRC, to improve health outcomes for affected infants and reduce serious complications associated with the disease.

METHODS

A prospective cohort pilot study was conducted from November 2022 to December 2023 in 15 primary healthcare facilities in Bukavu. Mothers were screened for SCD at antenatal clinics and maternities. Blood samples from mothers and newborns were collected and tested using the HemoTypeSC™ point-of-care testing. Results were confirmed by Gazelle® electrophoresis in case of a positive result.

RESULTS

Out of the 6,353 sensitized mothers, 4,496 consented to undergo screening, resulting in an acceptance rate of 70.77%. Among them, 91.61% were HbAA, 8.16% were HbAS, and 0.22% were HbSS. Among the mothers with HbS, only 77 received follow-up until delivery, demonstrating the feasibility of the follow-up process. The findings revealed that out of the 77 newborns, 66.23% were HbAA, 29.87% were HbAS, and 3.90% were HbSS.

CONCLUSIONS

The integration of newborn screening for SCD into primary health care in Bukavu, in the DRC, has demonstrated feasibility and effectiveness in the early identification of affected infants. This initiative has the potential to mitigate the serious complications linked to the disease and enhance health outcomes for patients. These findings set the stage for broader adoption of this approach to address the implications of SCD on maternal and child health in the DRC.

摘要

引言

镰状细胞病(SCD)是一种遗传性基因疾病,是撒哈拉以南非洲地区,尤其是刚果民主共和国(DRC)面临的一项重大公共卫生挑战。这种疾病的特征是β-珠蛋白链中的氨基酸替换,需要早期管理以减少严重并发症并提高患者的生活质量。本研究旨在测试在刚果民主共和国布卡武将新生儿镰状细胞病筛查纳入初级卫生保健的可行性,以改善受影响婴儿的健康结果并减少与该疾病相关的严重并发症。

方法

2022年11月至2023年12月在布卡武的15个初级卫生保健机构进行了一项前瞻性队列试点研究。在产前诊所和产科对母亲进行镰状细胞病筛查。采集母亲和新生儿的血样,并使用HemoTypeSC™即时检测进行检测。如果结果呈阳性,则通过Gazelle®电泳进行确认。

结果

在6353名接受宣传的母亲中,4496名同意接受筛查,接受率为70.77%。其中,91.61%为HbAA,8.16%为HbAS,0.22%为HbSS。在携带HbS的母亲中,只有77人在分娩前接受了随访,证明了随访过程的可行性。研究结果显示,在这77名新生儿中,66.23%为HbAA,29.87%为HbAS,3.90%为HbSS。

结论

在刚果民主共和国布卡武将新生儿镰状细胞病筛查纳入初级卫生保健已证明在早期识别受影响婴儿方面具有可行性和有效性。这一举措有可能减轻与该疾病相关的严重并发症,并改善患者的健康结果。这些发现为更广泛地采用这种方法来应对镰状细胞病对刚果民主共和国母婴健康的影响奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e77/12398986/76176c2790fd/12875_2025_2976_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验